Skip to content

Study on the application of Qingdu lotion in the treatment of HR-HPV infection based on the characteristics of cervical microflora

Study on the application of Qingdu lotion in the treatment of HR-HPV infection based on the characteristics of cervical microflora

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060568
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-06-06
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological inflammation

Interventions

Qingdu lotion group:Give Qingdu lotion to vagina after menstruation is clean.
Control group:None

Sponsors

Maoming Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-85 years old, have sexual history, but no sexual life 3 days before examination; 2. Single or multiple types of HR-HPV infection; 3. Non-menstruation, pregnancy or lactation; 4. No cervical lesions; 5. No history of gynecological tumor; 6. Follow the voluntary principle to participate in the experiment and sign the informed consent form; 7. They did not receive any anti-HPV treatment within 4 weeks before entering the group.

Exclusion criteria

Exclusion criteria: 1. The subjects took contraceptive, antibiotics, immunosuppressants, and other drugs 3 days before the examination; 2. The subjects were in the stage of acute inflammation (trichomonal vaginitis, candidal vaginitis, bacterial vaginosis, Mycoplasma infection, chlamydia infection, etc.); 3. Patients with LSIL or more cervical lesions were diagnosed by histopathological examination; 4. Those who have child-bearing requirements or are in pregnancy or lactation in the past six months; 5. Patients with severe primary diseases such as severe liver and kidney diseases and hematopoietic system; 6. Suffering from mental illness and unable to collaborate; 7. Those with a history of multiple drug or food allergies; 8. Patients with cervical polyps, previous cervical trauma, or physiotherapy for cervical lesions.

Design outcomes

Primary

MeasureTime frame
HPV;Vaginal microecology;Cervical microflora;

Countries

China

Contacts

Public ContactMingdan Tan

Maoming Traditional Chinese Medicine Hospital

tanmingdan@126.com+86 18813340066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026